In This Section

Program

Friday, October 2, 2020

Saturday, October 3, 2020

Sunday, October 4, 2020

Friday, October 2, 2020

Opening Session
10 a.m.-12 p.m.

Keynote speaker to be announced

Break
12-12:15 p.m.
Concurrent Session 1: Progress in Impact of Diversity and Inclusion in Clinical Trials
Co-Session Chairs: Worta McCaskill-Stevens, National Cancer Institute,  
Bethesda, Maryland; Martin Mendoza, Office of Minority Health, Rockville, Maryland 
12:15-1:45 p.m.

Lack of diversity in clinical research participation: Is this an equity imperative?
Nadine J. Barrett, Duke Cancer Institute, Durham, North Carolina

Title to be announced
Rear Admiral Richardae Araojo, U.S. Food and Drug Administration, Associate Commissioner for Minority Health, Silver Spring, Maryland

Achieving diversity and inclusion in clinical research: Critical role of community partnerships and collaborations
Luther T. Clark, Merck & CO., Rahway, New Jersey

How a person can use their privilege to help disparities
Julia Maues, GRASP Cancer, Washington, DC

Addressing racial health care disparities by advancing inclusive research
Melissa S. Gonzales, Genentech, South San Francisco, California

Concurrent Session 2: Health Care Policy in Advancing Cancer Health Equity
Co-Session Chairs: Brian M. Rivers, Morehouse School of Medicine, Atlanta, Georgia; Karen M. Winkfield, Wake Forest Baptist Medical Center, Winston-Salem, North Carolina
12:15-1:45 p.m.

Title to be announced
Raul Ruiz, U.S. Representative, California’s 36th District

Title to be announced
Lola Fashoyin-Aje, Food and Drug Administration, Silver Spring, Maryland

Re-examining the interplay between structure, cancer, and cancer health policy
Robert A. Winn, VCU Massey Cancer Center, Richmond, Virginia

How patient advocates can advance cancer health equity – Tales from the frontlines  
Lisa Laudico, SHARE Cancer Support- Our MBC Life Podcast, Westport, Connecticut

Break
1:45-2 p.m.   
Concurrent Session 3: Disparities in Cancer Risk and Treatment among the LGBTQ Population
Co-Session Chairs: Jesse Ehrenfeld, Vanderbilt University, Nashville, Tennessee; Matthew R. Schabath, Moffitt Cancer Center, Tampa, Florida
2-3:30 p.m.

The Prevent Anal Cancer Study: The assessment of novel opportunities for anal cancer screening during COVID-19
Alan Nyitray, Medical College of Wisconsin, Milwaukee, Wisconsin

Improving cultural humility training for oncology clinicians
Gwendolyn P. Quinn, New York University, Langone Medical Center, New York, New York

Title to be announced
Kellen Baker, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland

Concurrent Session 4: From Bench to Bedside to Community: Using Race/Ethnic-Appropriate Models in Precision Medicine
Session Chair: Luis Carvajal-Carmona, UC Davis, Davis, California
2-3:30 p.m.

Title to be announced
Luis Carvajal-Carmona 

Title to be announced
Bodour Salhia, USC Norris Comprehensive Cancer Center, Los Angeles, California

Title to be announced
Salma Kaochar, Baylor College of Medicine, Houston, Texas

Break
3:30-3:45 p.m.
Current Hot Topics in Cancer Health Disparities 1
3:45-5 p.m

Speakers to be announced

Concurrent Hot Topics in Cancer Health Disparities 2
3:45-5 p.m.

Speakers to be announced

Saturday, October 3

Plenary Session 1: Trans-disciplinary Convergence Approaches to Cancer Health Disparities Research
Co-Session Chairs: Chanita Hughes-Halbert, MUSC Hollings Cancer Center, Charleston, South Carolina; Robert A. Winn, Virginia Commonwealth University, Richmond, Virginia
10-11:30 a.m.

Title to be announced
Patrick Nana-Sinkam, Virginia Commonwealth University, Richmond, Virginia

Title to be announced
Nichole T. Tanner, Medical University of South Carolina, Charleston, South Carolina

Title to be announced
Christopher Lathan, Dana-Farber Cancer Institute, Boston, Massachusetts

Break
11:30-11:45 a.m.
Concurrent Session 5: Prevention, Screening, and Surveillance in the Adolescent Young Adult Cancer Population
Co-Session Chairs: Kimberly J. Johnson, Washington University in St. Louis, St.  Louis, Missouri; Jun J. Yang, St. Jude Children’s Research Hospital, Memphis, Tennessee
11:45 a.m.-1:15 p.m.

Genetic risk for subsequent breast cancer among female survivors of childhood cancer
Zhaoming Wang, St. Jude Children’s Research Hospital, Memphis, Tennessee

Second cancers and survival in adolescent and young adult cancer survivors
Theresa Keegan, University of California, Davis, Sacramento, California

Addressing gaps in health insurance literacy among adolescent and young adult cancer patients
Anne Kirchhoff, Huntsman Cancer Institute, Salt Lake City, Utah

Understanding causes of inferior survival in adolescent and young adults with acute lymphoblastic leukemia
Smita Bhatia, University of Alabama at Birmingham, Birmingham, Alabama

Concurrent Session 6: Biology of Cancer Disparities and Potential Impact on Precision Oncology in Diverse Populations
Co-Session Chairs: Camille Ragin, Fox Chase Cancer Center, Philadelphia, Pennsylvania; Clayton C. Yates, Tuskegee University, Tuskegee, Alabama
11:45 a.m.- 1:15 p.m.

Title to be announced
Catherine Hoyo, North Carolina State University, Raleigh, North Carolina

Biology of aggressive breast cancer in women of African descent
Tomi Akinyemiju, Duke University School of Medicine, Durham, North Carolina

Black Lives Matter worldwide: Retooling precision oncology for true equity of cancer care
Olufunmilayo I. Olopade, University of Chicago Comprehensive Cancer Center, Chicago, Illinois

Break
1:15-1:30 p.m.
Concurrent Session 7: Cancer Clinical Trial Inclusion and Diversity- Challenges and Opportunities
Co-Session Chairs: Windy Dean-Colomb, Our Lady of Lourdes JD Moncus Cancer Center, Lafayette, Louisiana; Lewis R. Roberts, Mayo Clinic, Rochester, Minnesota
1:30 p.m.- 3 p.m.

Learning from and addressing racial and ethnic disparities in cancer clinical trials: The ECOG-ACRIN experience
Joseph A. Sparano, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, New York

A survivor perspective: The imperative to act on what we know
Dicey Scroggins, International Gynecologic Cancer Society, Pinkie Huggs, LLC, Washington, DC

Addressing cancer disparity from a global perspective: Increasing participation in trans-national clinical trials 
Windy Dean-Colomb, Mitchell Cancer Institute, University of South Alabama, Mobile, Alabama

Concurrent Session 8: Addressing Disparities in Survivorship- Supportive, Palliative, and End-of-Life Care
Co-Session Chairs: Kimlin T. Ashing, City of Hope, Durate, California; Diana J. Wilkie, University of Florida, Gainesville, Florida
1:30-3 p.m.

Addressing psychosocial health disparities among Latina breast cancer survivors
Anna Napoles, National Institute on Minority Health and Health Disparities, Bethesda, Maryland

Title to be announced
Tammie Quest, Winship Cancer Institute of Emory University, Atlanta, Georgia

Structural inequities, social determinants, and survivorship: Opportunities and strategies to advance health equity
Kassandra I. Alcaraz, Georgia State University School of Public Health, Atlanta, Georgia

Break
3-3:15 p.m.
Concurrent Hot Topics in Cancer Health Disparities 3
3:15-4:30 p.m.

Speakers to be announced

Concurrent Hot Topics in Cancer Health Disparities 4
3:15-4:30 p.m.

Speakers to be announced

Sunday, October 4

Concurrent Session 9: Understanding the Role of Cancer Immunology and the Tumor Microenvironment in Cancer Health Disparities
Co-Session Chairs: Melissa B. Davis, Weill Cornell, New York, New York; Luis A. Diaz, Memorial Sloan Kettering Center Center, New York, New York
10- 11:30 a.m.

The immunogenomic landscape of primary prostate cancer in African-American men
Tamara Lotan, Johns Hopkins University, Baltimore, Maryland

Distinct heterogeneous subtypes of triple-negative breast cancer associated with African ancestry
Melissa B. Davis

Novel biological insights into colorectal cancer from West Africa
T. Peter Kingham, Memorial Sloak Kettering Cancer Center, New York, New York

Concurrent Session 10: Opportunities and Challenges in Global Cancer Disparities Research
Co-Session Chairs: Folakemi T. Odedina, University of Florida, Orlando, Florida; Gilberto de Lima Lopes, University of Miami, Miami, Florida
10- 11:30 a.m.

Cancer disparity in Sub-Saharan Africa: Challenges and opportunities                                     
Abubakar Bello, National Hospital, Abuja, Nigeria

Title to be announced
Gilian Wharfe, University of the West Indies at Mona, Kingston, Jamaica

A perspective on global cancer disparities from the NCI Center for Global Health
Satish Gopal, Center for Global Health, National Cancer Institute, Bethesda, Maryland

Title to be announced
Delva Shamley, University of Cape Town, Cape Town, South Africa

Break
11:30- 11:45 a.m.
Concurrent Session 11:  Advanced Molecular Technologies in Cancer Disparities Discovery Research
Co-Session Chairs: John D. Carpten, University of Southern California, Los Angeles, California; Jelani C. Zarif, Johns Hopkins School of Medicine, Baltimore, Maryland 
11:45-1:15 p.m.

Single cell comparative biology of human and mouse prostate cancer
Vasan Yegnasubramanian, Johns Hopkins School of Medicine, Baltimore, Maryland

Novel approaches for assessing molecular heterogeneity
Lee Gibbs, Keck School of Medicine of University of Southern California, Los Angeles, California

Advances in genomic characterization of multiple myeloma and its precursor states
Mark W. Bustoros, Dana-Farber Cancer Institute, Boston, Massachusetts

Concurrent Session 12: Disparities in Cancer Outcomes: Biology, Access, and Equity
Session Chair: Timothy R. Rebbeck, Dana-Farber Cancer Institute, Boston, Massachusetts
11:45-1:15 p.m.

Biological and social influences on disparities in prostate cancer mortality
Timothy R. Rebbeck 

Title to be announced 
Sandi L. Pruitt, UT Southwestern Medical Center, Dallas, Texas

Title to be announced 
Clayton C. Yates, Tuskegee University, Tuskegee, Alabama

Break
1:15-1:30 p.m.
Plenary Session 2: Innovation in Growing a Diverse Workforce in Cancer Research
Co-Session Chairs: Sanya A. Springfield, National Cancer Institute, Bethesda, Maryland; Alison Lin, National Cancer Institute, Bethesda, Maryland
1:30-3 p.m.

Title to be announced
Alden Landry, Harvard Medical School, Boston, Massachusetts

Engagement with Native American communicites
Maurice Godfrey, University of Nebraska Medical Center, Omaha, Nebraska

Title to be announced
Joan Y. Reede, Harvard Medical School, Boston, Massachusetts

Title to be announced
Frederick Kron, Medical Cyberworlds, Inc., Madison, WI

Closing Remarks
3-3:10 p.m.